Copyright
©The Author(s) 2020.
World J Gastrointest Endosc. Nov 16, 2020; 12(11): 408-450
Published online Nov 16, 2020. doi: 10.4253/wjge.v12.i11.408
Published online Nov 16, 2020. doi: 10.4253/wjge.v12.i11.408
Ref. | Year | Country | Study design | n | Procedure | Medication | Relative risk |
Schoepfer et al[80] | 2010 | United States | Prospective | 207 | Dilatation (EoE) | No medications | No incidence of PPB |
Ally et al[81] | 2013 | United States | Retrospective | 66 | Dilatation (EoE) | No medications | No incidence of PPB |
Jung et al[82] | 2011 | South Korea | Retrospective | 293 | Dilatation (EoE) | No medications | Incidence of PPB 0.3% |
Dellon et al[83] | 2010 | United States | Retrospective | 70 | Dilatation (EoE) | No medications | No incidence of PPB |
- Citation: Chan A, Philpott H, Lim AH, Au M, Tee D, Harding D, Chinnaratha MA, George B, Singh R. Anticoagulation and antiplatelet management in gastrointestinal endoscopy: A review of current evidence. World J Gastrointest Endosc 2020; 12(11): 408-450
- URL: https://www.wjgnet.com/1948-5190/full/v12/i11/408.htm
- DOI: https://dx.doi.org/10.4253/wjge.v12.i11.408